Journal of Breast Imaging, Volume 6, Issue 5 Educational Review Article: "Imaging Features and WHO Classification of Rare Breast Tumors"
Title of Activity: Imaging Features and WHO Classification of Rare Breast Tumors
Date(s) of Activity: CE Release Date: September 3, 2024 – CE Expiration Date: September 2, 2027
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Society of Breast Imaging. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163
ACCME Credit Designation Statement: Amedco LLC designates this activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Satisfactory Completion: Learners must read the article in its entirety and complete an evaluation form to receive a certificate of completion. The activity must be attended in its entirety, as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Acknowledgement of Financial Commercial Support: No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support: No in-kind commercial support was received for this educational activity.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5). All individuals in a position to control the content of CE are listed below.
Liva Andrejeva-Wright, MD: NA
Natalie Ward: NA
Ryan Dixon: NA
- Develop a basic understanding of the World Health Organization classification of breast lesions based on their cellular origin.
- Become familiar with the imaging and pathologic appearance of infrequent breast lesions and learn about the management of such lesions.
- Develop a broader differential diagnosis of breast lesions.